Phase Ii clinical study of Yoshi 864 in epithelial ovarian carcinoma: a Gynecologic Oncology Group Study
Slavik, M.; Muss, H.; Blessing, J.A.; Delgado, G.
Cancer Treatment Reports 66(9): 1775-1777
1982
ISSN/ISBN: 0361-5960 PMID: 6288239 Document Number: 196892
Document emailed within 1 workday
Related Documents
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424Stehman, F.B.; Blessing, J.A.; Delgado, G.; Louka, M. 1983: Phase Ii evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study Cancer Treatment Reports 67(7-8): 737-738
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Thigpen, T.; Vance, R.B.; McGuire, W.P.; Hoskins, W.J.; Brady, M. 1995: The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience Seminars in Oncology 22(6 Suppl 14: 23-31
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Feng, Z.; Wen, H.; Liao, Q. 2014: Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines Zhonghua Fu Chan Ke Za Zhi 49(10): 780-786
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Yakushiji, M.; Abe, M.; Tsunawaki, A.; Nishimura, H.; Kato, T. 1980: Clinical study on the treatment of malignant ovarian tumor--particularly the clinical management of dysgerminoma and common epithelial carcinoma Nihon Sanka Fujinka Gakkai Zasshi 32(11): 1879-1887
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15
Hreshchyshyn, M.M. 1975: Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report National Cancer Institute Monograph 42: 155-165
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Boros, L.; Tsiatis, A.A.; Neiman, R.S.; Mann, R.B.; Glick, J.H. 1986: Phase Ii Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma Cancer Treatment Reports 70(7): 917-918
Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W. 2000: Phase Ii study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer European Journal of Gynaecological Oncology 21(6): 610-612
Luesley, D.M.; Williams, D.R.; Ward, K.; Redman, C.R.; Lawton, F.G. 1990: Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease Acta Cytologica 34(4): 539-544
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H. 1987: Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1313-1314
Takano, M.; Kikuchi, Y.; Kita, T.; Suzuki, M.; Ohwada, M.; Yamamoto, T.; Yamamoto, K.; Inoue, H.; Shimizu, K. 2002: Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer Anticancer Research 22(3): 1833-1838